Valine Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Valine Market is segmented By Product Type (L-Valine, D-Valine), By Application (Feed Industry, Food Industry, Pharmaceutical Industry, Others), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Valine Market Overview

The Global "Valine Market" is predicted to reach at a high CAGR of 2.7% during the forecast period (2024-2031). North American and Asia-pacific regions have a high demand for valine as there is rising consumption of valine contained food products and supplements in the region.

Valine Market Scope

Get A Free Sample Click Here

Valine is a non-polar aliphatic essential branched-chain amino acid. Leucine and isoleucine are also other non-polar amino acids. It is extremely hydrophobic and is found in many proteins. It is important for humans as it cannot be synthesised by the body. It is synthesised by the plants and is also important for muscle growth, tissue repair and energy. Valine comes from the name valeric acid which is named after a plant called valerian. Valine is linked to insulin resistance. Valine is found in meats, soy, fish, nuts/vegetables, dairy products etc.

Valine Market Dynamics

The major factor driving the rising demand for Global Valine is the high usage of Valine in food products and supplements and people are nowadays becoming more aware of the advantages and disadvantages of valine in our diet.

Increasing Usage of Valine in the Food Products and Supplements is driving the market growth

The demand for food products and supplements having Valine as the major ingredient is on the rise and it is expected that people will prefer more food products having Valine in the future as nowadays people are quite concerned about their health and prefer healthy food and diet. Even sportspersons and gym freak people are consuming the supplements containing Valine. Valine prevents wear and tear of muscles and it also helps in improving the performance of the athlete, sportsperson and also boosts the immune system. It also improves concentration.

Increasing Awareness About the Positives and Negatives of Valine and Development of New Products is driving the market growth

Nowadays, people are becoming more aware of the advantages and disadvantages of Valine contained food products and supplements, like sportspersons, are using Valine supplements to improve their performance and to prevent wear and tear of muscles. Valine is also important for muscle growth, tissue repair and energy. The government is also supporting the use of valine in animal husbandry which in turn increasing the demand for feed grade valine. Governments also provide feed grade value at subsidised rates. It helps in enhancing the growth of animals as it is a source of energy for the muscles. Many companies are focusing on the development of new valine products like Evonik Industries Launched a feed grade L-valine called ValAmino. In 2019, EPPEN biotech announced the project of changing the production line of 50,000 t/a L-threonine to a production line of 20,000 t/a L-valine and it will also produce L-valine for feed grade with the capacity of 17,163 tonnes and 2,000 t/a L-valine for food-grade as well as 121 t/a TMP in the future. The motive of the project is to make L-valine the main product of the company.

Availability of substitutes to the valine like other branched-chain amino acids is hampering the  growth of the Global Valine Market

COVID-19 Impact Analysis on Valine Market

The Global Valine Market has shown a slight decline due to the COVID-19 pandemic, as there were full or partial lockdowns in many countries of the world. WHO declared covid-19 as a pandemic in 2020, due to which travel restrictions were imposed in different parts of the world. China is the largest producer of Valine and due to the pandemic, production was disrupted.  Even gyms, playgrounds, and parks were closed around the world, so the demand for valine among athletes, sportspersons, and gym freak people was also less. The supply chain was disrupted and due to which the valine market declined during covid-19. It is expected that the market will grow in the future as covid-19 has given us the lesson that health is more important than other things in our life and people are nowadays becoming more aware of valine and preferring healthy foods and supplements. Valine has an important role in the pharmaceutical industry as it is used for lowering the high blood sugar levels, preventing wear and tear of muscles, boosts the immune system and the valine deficiency diseases are also rising in the world, due to which valine is quite important in the pharmaceutical industry. Even during the covid-19 pandemic, there was a huge growth in the pharmaceutical companies and it is expected that the industry will grow in the future due to the high demand for vaccines, drugs for covid-19 vaccination and treatment. The total sales of pharmaceutical products in the world was increased from $1030 in 2019 to $1070 in 2020 and it was only $970 in 2018There are many medicines containing valine like Synthamin 9, Triomel, Travasol, Prosol, Clinimix etc.  The high demand from the pharmaceutical industry is driving the market for valine even during the covid-19 pandemic. The global pharmaceutical industry was valued at USD 1.2 trillion in 2020. Valine is also important in the food industry but during covid-19 ready to eat, packaged foods were preferred. L-valine is also used in the production of various pharmaceuticals like Cbz-L-valine, Boc-L-valine etc

Valine Market Segment Analysis

Global Valine is segmented based on Product Type, Application, and Region.

Based on the Type, the Global Valine Market is segmented into L-Valine and D-Valine.

L-Valine is an L-enantiomer of valine having codons such as GUU, GUC, GUA and GUG. L- valine has the highest market share as there is increasing demand for L-valine in the food industry, pharmaceuticals, agriculture and other industries, it is also used as an additive to animal feed for providing energy to the muscles, which also helps in enhancing the growth of the animals. L-valine is also used in the production of various pharmaceuticals like Cbz-L-valine, Boc-L-valine etc. It is also used in the production of herbicides. A low protein level diet can be covered using L-valine. CJ Cheiljedang company has an important L-valine BestAmino in its product portfolio.

D-valine is a D-enantiomer of valine and also enantiomer of L-valine. D-valine is a non-coded isomer of valine that is used as a selective cell inhibitor as it inhibits the cells that do not have an enzyme called D-amino acid oxidase. It is also used in the production of pesticides like pyrethroids permethrin and chlorofluorocarbons amyl. It also has significant usage in chiral pharmaceuticals, chiral additives and also in the production of drugs that allows the selective epithelial cells to grow and inhibiting the growth of fibroblast.

Valine Market Geographical Analysis

Based on Region, the Global Valine is segmented as - North America, Europe, Asia-Pacific, Middle East, Africa, South America.

North American and Asia-pacific regions have a high demand for valine as there is rising consumption of valine contained food products and supplements in the region. Nowadays people are becoming more aware of the advantages of valine and even due to growing health concerns and diseases, people are preferring healthy food products, people are now focusing on being fit and changing their lifestyle and doing exercises, building their body in the gym which is driving the market growth of valine. An increase in Valine deficiency diseases like hypotonia is also driving the market growth. Hypotonia is the condition when there is a low level of muscle tone, deficiency of valine also leads to reduced growth and organ damage. North America has the highest market share due to the high demand from the pharmaceutical industry. The USA is one of the biggest exporters of pharmaceuticals in the world with total exports worth USD 24.3 billion in 2019. The North American region had an 8.2% market share of the world in exporting pharmaceuticals. According to a report by the Pharmaceutical Research and Manufacturers Association (PhRMA), the companies of the US have been involved in around half the world's Research & Development activities of pharmaceuticals worth USD 75 Billion and spend nearly 20% of their total revenue in R&D activities. The companies also hold the intellectual property rights on the newest medicines.  Some of the major pharmaceutical companies of the region are Pfizer, Johnson & Johnson, Moderna, etc. Even during the covid-19 pandemic, there was a huge growth in the pharmaceutical companies and it is expected that the industry will grow in the future due to the high demand for vaccines, drugs for covid-19 vaccination, and treatment. There are many medicines containing valine like Synthamin 9, Triomel, Travel, Prosol, Clinimix etc. US Pharmaceutical industry had total revenue of USD 490 billion in 2019. Total sales of pharmaceutical products in the US were around USD 510 billion in 2020.

Valine Companies and Competitive Landscape

Global Valine  Market is fragmented with key global players in the market. Some of the major companies contributing to the market's growth are- Ajinomoto Co., Inc, Evonik Industries AG, Kyowa Hakko Bio Co., Ltd, CJ Cheiljedang Corporation, Wellman Bioscience, Luzhou Group, Star Lake Bioscience Co., Inc Meihua Group, Wuxi Jinghai Amino Acid Co., Ltd, Fufeng Group, etc.

Mergers and Acquisitions, expansions, joint ventures etc increases competition in the market such as Ajinomoto Althea and OmniChem merged to form Ajinomoto Bio-Pharma Services in October 2018, Meihua Group made an agreement with Ajinomoto for the supply of amino acids in August 2017.

New products, services launched, partnerships, and agreements also increase competition between companies like Ajinomoto group conducted the renewal of its sports nutrition product Amino Vital Pro in 2019 and EPPEN biotech announced the project in 2019 to make L-valine the most important product of the company and the project involves changing the production line of 50,000 t/a L-threonine to a production line of 20,000 t/a L-valine and it will also produce L-valine for feed grade with the capacity of 17,163 tonnes and 2,000 t/a L-valine for food-grade as well as 121 t/a TMP in the future. Ajinomoto launched Group Nutrient Profiling System(ANPS) for Product to about 500 kinds of group products in seven countries which includes Japan, Thailand, Vietnam, Indonesia, Philippines, Malaysia, and Brazil in April 2020.  Even the new and emerging companies are challenging the old and established companies by using planned strategies like CJ Cheiljedang, a Korean food company is becoming one of the top companies in the field due to its marketing strategy which highlights the important points like how to use valine and also has a large production system. CJ became the top player in this market when the total revenue of the company was USD 11.22 billion in 2019 surpassing the Ajinomoto company revenue of USD 11.12 billion in 2019.

Ajinomoto Co

Overview:

Ajinomoto is a Japanese company dealing with the food industry which operates in 35 countries of the world. The headquarters of the company is in Chuo, Tokyo, Japan. The company’s product portfolio includes pharmaceuticals, cooking oils, sweeteners, etc. The company was founded in 1907 by Saburosuke Suzuki II and Dr. Kikunae Ikeda. Dr. Kikunae Ikeda was a professor at Tokyo Imperial University. The company sold Amoy food to the CITIC group in 2018. Amoy food is a food company in Hong Kong that manufactures frozen foods, cooking sauces, etc. Ajinomoto launched its ‘Global Brand Logo’ in 2017. Ajinomoto Althea and OmniChem merged in October 2018 to form Ajinomoto Bio-Pharma Services. According to the report, Ajinomoto joined the international environment initiative RE100 in 2020. RE100 is the global environment initiative that brings the companies to use 100% renewable energy and currently has more than 300 members.

According to the Forbes global 2000 ranking, the company was ranked 1275 in 2021. The market value of the company is USD 11.1 billion. The Domestic Food Products division of the company deals with frozen food, seasonings, and processed foods. The healthcare division deals with pharmaceuticals, the life support division deals with amino acids for pharmaceuticals, sweeteners, chemicals, etc. The Overseas Food Products division deals with consumer foods like flavor seasonings and instant noodles etc. The Others division deals with the healthcare business, partnership business, logistics, and packaging business. Ajinomoto is the first Japanese company to introduce a method to estimate the nutritive value of products like powdered soup and frozen foods.  Group Nutrient Profiling System(ANPS) for Product was launched to about 500 kinds of group products in seven countries which includes Japan, Thailand, Vietnam, Indonesia, Philippines, Malaysia, and Brazil in April 2020.

Product Portfolio:

• Fusi-BCAA
• AjiPure
• AjiPro-L
• amino Vital
• L-valine
• L-threonine
• L-Tryptophan
• L-Lysine
• Marim
• Blendy
• Sen
• Birdy

Key Development

• Ajinomoto joined the international environment initiative RE100  in 2020, a global initiative for companies to use 100% renewable energy.
• Ajinomoto sold Amoy food, a food company based in Hong Kong to the CITIC group in 2018.
• Ajinomoto Althea and OmniChem merged to form Ajinomoto Bio-Pharma Services in October 2018.
• The Ajinomoto Group Nutrient Profiling System for Product was launched to about 500 kinds of group products in seven countries of the world in April 2020. It is a method to estimate the nutritive value of products like powdered soup and frozen foods

Financial Overview

Major shareholders of the company are Nomura Asset Management Co., Ltd, Nippon Life Insurance Co, Sumitomo Mitsui Trust Asset Management Co., Ltd, Nikko Asset Management Co., Ltd with market shares of 5.66%, 4.68%, 3.29%, 2.98% respectively. According to the Forbes global 2000 ranking, the company was ranked 1275 in 2021. The market value of the company is USD 11.1 billion.

Why Purchase the Report?

• Visualize the composition of the Global Valine market products in terms of source, application, and end-user industry highlighting the critical commercial assets and players.
• Identify commercial opportunities in the Global Valine market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of Global Valine market-level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The Global Valine market report will provide access to approximately 53 market data tables, 44 figures, and 200 pages

Target Audience 2024

• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Emerging Companies
• Research professionals
• Distributors
• Manufacturers